Fingerprint
Dive into the research topics of 'Fully human glyco-optimized recombinant FSH (follitropin epsilon) – a randomized, comparator-controlled phase II clinical trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Fully human glyco-optimized recombinant FSH (follitropin epsilon) – a randomized, comparator-controlled phase II clinical trial
Georg Griesinger*, Bruno Dietrich, Lars Stöckl, Kelvin Eckert, Steffen Goletz, Andreas Tandler-Schneider
*Corresponding author for this work
2
Citations
(Scopus)